Related Experiment Videos
[Ultrasonically nebulized hypertonic saline as a provocation agent in asthmatics]
1Department of Respiratory Disease, XiJing Hospital, China.
Summary
Inhaled hypertonic saline (HS) effectively identifies bronchial hyperreactivity in most asthma patients. This simple, rapid method correlates well with methacholine challenges for assessing airway responsiveness.
Area of Science:
- Respiratory Medicine
- Pulmonology
- Clinical Physiology
Context:
- Assessing bronchial hyperreactivity is crucial for asthma management.
- Traditional methacholine challenges can be time-consuming and costly.
- A need exists for simpler, more accessible methods to evaluate airway responsiveness.
Purpose:
- To evaluate the efficacy and simplicity of inhaled hypertonic saline (HS) as a challenge agent for determining bronchial hyperreactivity.
- To compare the bronchial response to HS with that of methacholine (MCH).
Summary:
- Twenty-six subjects with stable asthma underwent hyperosmotic challenge using increasing concentrations of inhaled hypertonic saline (2.7-7.2%).
- Twenty-three subjects (88%) demonstrated responsiveness to HS, with a PC20-HS ranging from 1.65 to 6.06%.
- The peak bronchoconstrictor effect occurred at 3 minutes post-inhalation, lasting approximately 45 minutes. A significant correlation (r=0.538, P<0.01) was found between PC20-HS and PC20-MCH.
Impact:
- The hypertonic saline challenge is a simple, rapid, and inexpensive method for assessing bronchial hyperreactivity.
- This technique offers a valuable new tool for determining airway responsiveness in asthma.
- Findings support HS as a practical alternative or adjunct to methacholine challenges in clinical settings.